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Macrophage Polarization Modulates 
Fcγr- and cD13-Mediated 
Phagocytosis and reactive Oxygen 
species Production, independently 
of receptor Membrane expression
Elizabeth Mendoza-Coronel and Enrique Ortega*
Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad 
Universitaria, Mexico City, Mexico
In response to microenvironmental cues, macrophages undergo a profound phenotypic 
transformation acquiring distinct activation phenotypes ranging from pro-inflammatory 
(M1) to anti-inflammatory (M2). To study how activation phenotype influences phago-
cytosis and production of reactive oxygen species (ROS) mediated by receptors for 
IgG antibodies (Fcγ receptors) and by CD13, human monocyte-derived macrophages 
were polarized to distinct phenotypes using IFN-γ (Mϕ-IFN-γ), IL-4 (Mϕ-IL-4), or IL-10 
(Mϕ-IL-10). Phenotypically, Mϕ-IFN-γ were characterized as CD14+CD80+CD86+ cells, 
Mϕ-IL-4 as CD209highCD206+CD11b+CD14low, and Mϕ-IL-10 as CD16+CD163+ cells. 
Compared to non-polarized macrophages, FcγRI expression increased in Mϕ-IFN-γ and 
Mϕ-IL-10 and FcγRIII expression increased in Mϕ-IL-10. None of the polarizing cytokines 
modified FcγRII or CD13 expression. Functionally, we found that cytokine-mediated acti-
vation significantly and distinctively affected FcγR- and CD13-mediated phagocytosis 
and ROS generation. Compared to non-polarized macrophages, FcγRI-, FcγRII-, and 
CD13-mediated phagocytosis was significantly increased in Mϕ-IL-10 and decreased 
in Mϕ-IFN-γ, although both cytokines significantly upregulated FcγRI expression. IL-10 
also increased phagocytosis of Escherichia coli, showing that the effect of IL-10 on 
macrophage phagocytosis is not specific for a particular receptor. Interestingly, Mϕ-IL-4, 
which showed poor FcγR- and CD13-mediated phagocytosis, showed very high phago-
cytosis of E. coli and zymosan. Coupled with phagocytosis, macrophages produce ROS 
that contribute to microbial killing. As expected, Mϕ-IFN-γ showed significant production 
of ROS after FcγRI-, FcγRII-, or CD13-mediated phagocytosis. Unexpectedly, we found 
Abbreviations: ATCC, American Type Culture Collection; Carboxy-H2DFFDA, 5-(and-6)-carboxy-2′,7′-
difluorodihydrofluorescein diacetate; CD13, cluster of differentiation 13, aminopeptidase N; CFSE, carboxyfluorescein suc-
cinimidyl ester; EBS-Fab, sheep red blood cells labeled with CFSE and coated with biotin, streptavidin, and biotin-labeled 
bivalent antigen-binding fragments of anti-IgG; F(ab′)2, bivalent antigen-binding fragments of antibodies (disulfide bond 
joined); FcγRs, receptors for the Fc portion of immunoglobulin G; FcγRI, type 1 high-affinity receptor for the Fc portion 
of immunoglobulin G (CD64); FcγRII, type II receptor for the Fc portion of immunoglobulin G (CD32); FcγRIII, type III 
receptor for the Fc portion of immunoglobulin G (CD16); Mϕ, macrophage; hMDM, human monocyte-derived macrophage; 
Mϕ-IFN-γ, IFN-γ-treated macrophages; Mϕ-IL-4, IL-4-treated macrophages; Mϕ-IL-10, IL-10-treated macrophages; M-CSF, 
macrophage colony-stimulating factor; PI, phagocytic index; ROS, reactive oxygen species; SRBC, sheep red blood cells.
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inTrODUcTiOn
Macrophages are a phenotypically and functionally heterogene-
ous group of myeloid cells, with a high degree of plasticity. In tis-
sues, macrophages respond to the local cytokine milieu with the 
acquisition of distinct functional phenotypes. In response to TLRs 
ligands and IFN-γ, macrophages undergo classical M1 activation, 
whereas they undergo alternative M2 activation after stimulation 
by IL-4/IL-13 or other stimuli. The M1-M2 model of macrophage 
polarization was proposed to reflect the Th1–Th2 polarization of 
T cells’ responses (1). The M1 phenotype is characterized by secre-
tion of high levels of pro-inflammatory cytokines, high produc-
tion of reactive nitrogen and oxygen intermediates, promotion of 
Th1 responses, and strong microbicidal and tumoricidal activity 
(2–5). On the other hand, M2 phenotype, originally designating 
the phenotype obtained by treatment of macrophages with IL-4, 
has been subdivided into various phenotypes: M2a (induced 
by IL-4 or IL-13), M2b (induced by immune complexes plus 
bacterial LPS), and M2c (induced by IL-10, glucocorticoids, and 
TGF-β) (2). M2a macrophages are characterized by the expres-
sion of mannose receptors and production of ornithine and 
polyamines through the arginase pathway, and are important in 
infections by parasites, allergy, and type II inflammation. M2c 
macrophages are characterized by high expression of scavenger 
receptors and higher production of IL-10, and are important in 
immunoregulatory functions and tissue remodeling (3, 5, 6).
Phagocytosis, endocytosis, secretion, and microbial killing are 
among the main functions of macrophages both in homeostasis 
and during microbial or damage-related threats (7). Phagocytosis 
is an essential function for the removal of dead or dying cells, tissue 
remodeling, and host defense. Phagocytosis is an actin-dependent 
process used by phagocytes to internalize particles greater than 
0.5  μm in diameter (8–10). In monocytes and macrophages, 
phagocytosis can be mediated by a wide variety of phagocytic 
receptors, including receptors for IgG antibodies (FcγRs) and 
CD13. FcγRs are among the best characterized phagocytic recep-
tors. Binding of IgG-opsonized particles to FcγRs on the surface 
of a phagocyte induces crosslinking of the receptors and triggers 
a series of cellular responses that are important for inflammation 
and immunity. These responses include phagocytosis, produc-
tion of reactive oxygen species (ROS), antibody-dependent 
cell-mediated cytotoxicity, release of pro-inflammatory media-
tors, and production of cytokines (11, 12). For its part, CD13 is 
a membrane peptidase, which participates in a wide variety of 
functions (13). CD13 is highly expressed on myeloid cells, and we 
have recently shown that in human monocytes and macrophages, 
CD13 is a competent phagocytic receptor capable of mediating 
phagocytosis, independently of other receptors (14). CD13 can 
also modulate phagocytosis mediated by FcγRs (15) and by other 
receptors (16). In addition, CD13 crosslinking induces ROS 
production in macrophages (14).
Cytokine-mediated activation of macrophages is known to 
regulate the expression of many different membrane receptors, 
including the different classes of FcγRs (17, 18). Usually, it is 
presumed that changes in the expression level of a given receptor 
results in corresponding changes in the magnitude of the responses 
mediated by the receptor. However, we (19) and others (20, 21) 
have reported a lack of correlation between changes in expression 
levels of FcγRs and phagocytosis or antibody-mediated cell cyto-
toxicity mediated by them. To test the hypothesis that the ability 
of a cell to perform specific receptor-mediated functions depends 
more on the polarization state of the cell than on the expression 
level of the receptor, we activated human macrophages to three 
distinct functional phenotypes and comparatively determined 
the expression levels of FcγRs and CD13, as well as phagocytosis 
and ROS production mediated by these receptors. Our results 
demonstrate that the polarization state of macrophages, more 
than changes in receptor expression, determines the cell’s capac-
ity for phagocytosis and production of ROS.
MaTerials anD MeThODs
reagents and antibodies
Fetal bovine serum (FBS), RPMI-1640 medium, sodium pyruvate 
solution, MEM non-essential amino acids solution, l-glutamine, 
penicillin, and streptomycin were purchased from Gibco Life 
Technologies (Carlsbad, CA, USA). Lymphoprep was from 
Axis-Shield PoC AS (Oslo, Norway). Recombinant human IFN-γ 
(rhIFN-γ), recombinant human IL-10 (rhIL-10), and recombinant 
human IL-4 (rhIL-4) were purchased from PeproTech (Rocky 
Hill, NJ, USA). Carboxy-H2DFFDA and carboxyfluorescein 
succinimidyl ester (CFSE) were from Molecular Probes by Life 
Technologies (Eugene, OR, USA). Sulfo-NHS-Biotin was from 
Thermo Scientific (Waltham, MA, USA); streptavidin was from 
Calbiochem (San Diego, CA, USA), and bovine serum albumin 
(BSA) was from Sigma (St. Louis, MO, USA). All culture media 
were supplemented with 10% heat-inactivated FBS and 1  mM 
sodium pyruvate, 0.1  mM non-essential amino acids solution, 
0.1  mM l-glutamine, 100  U/mL penicillin, and 100  μg/mL 
streptomycin (complete media). Cultures were maintained in a 
humidified atmosphere at 37°C with 5% CO2. Murine monoclo-
nal anti-hCD13 (clone 452, IgG1) was purified in our laboratory 
from culture supernatants of the hybridoma, kindly donated by 
Dr. Meenhard Herlyn (Wistar Institute of Anatomy and Biology, 
Philadelphia, PA, USA). Murine monoclonal IgG1 anti-human 
FcγRI (clone 32.2) and murine monoclonal IgG2a anti-human 
that Mϕ-IL-10 can also produce ROS after simultaneous stimulation through several 
phagocytic receptors, as coaggregation of FcγRI/FcγRII/CD13 induced a belated but 
significant ROS production. Together, these results demonstrate that activation of mac-
rophages by each cytokine distinctly modulates expression of phagocytic receptors, 
FcγR- and CD13-mediated phagocytosis, and ROS production.
Keywords: macrophage activation, cytokines, macrophage effector functions, M1–M2 macrophages, phagocytosis
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FcγRII (clone IV.3) mAbs were purified in our laboratory from 
supernatants of the corresponding hybridomas obtained from 
American Type Culture Collection. Fab fragments of the antibod-
ies were prepared with immobilized ficin (Pierce, Rockford, IL, 
USA) following the manufacturer’s instructions.
Biotin-F(ab′)2 fragments of goat anti-mouse IgG (H + L) were 
from Zymed (Invitrogen) and from Life Technologies (Eugene, 
OR, USA). Goat anti-mouse-FITC, used as a secondary antibody 
for immunostaining, was from Zymed (Invitrogen). Monoclonal 
mouse anti-human CD14 (clone RM032, IgG2a) was from Beckman 
Coulter Company (CA, USA). Monoclonal mouse anti-human CD80 
(clone 2D10, IgG1) was from BioLegend (San Diego, CA, USA). 
Monoclonal mouse anti-human CD209 (clone DCN 47.5, IgG1) was 
from Miltenyi Biotec (Bergisch Gladbach, Germany). Monoclonal 
mouse anti-human CD11b (clone ICRF44, IgG1), CD11c (clone 
B-ly6, IgG1, κ), CD86 (clone 2331 [FUN-1], IgG1), CD206 (clone 
19.2, IgG1), CD163 (clone GHI/61, IgG1, κ), and CD16 (clone 3G8, 
IgG1, κ) were all from BD Pharmingen (San Diego, CA, USA). 
Trizol, Turbo DNA-free kit, Oligo (dT) 12–18 primers and dNTP 
Mix 10 nM were from Invitrogen. Moloney Murine Leukemia Virus 
Reverse Transcriptase (M-MLV-RT) was from Promega. SYBR 
Green PCR Master Mix was from Applied Biosystems.
human Monocyte-Derived Macrophages 
(hMDMs) and In Vitro Polarization
Buffy coats from healthy male donors were obtained from the 
Central Blood Bank of the Centro Médico Nacional Siglo XXI, 
IMSS, which also approved of their use for these experiments. 
All experiments carried out with cells from human donors were 
performed following the Ethical Guidelines of the Instituto de 
Investigaciones Biomédicas, UNAM, Ciudad de México, México. 
PBMCs were isolated from buffy coats by gradient centrifuga-
tion with Lymphoprep. PBMCs were washed three times with 
PBS, pH 7.4, and were seeded (8–10  ×  107 PBMCs/plate) in 
100 mm × 20-mm cell culture-treated polystyrene culture dishes 
(Corning 430167, New York, NY, USA), in RPMI-1640 medium 
supplemented with 10% (v/v) heat-inactivated autologous 
plasma-derived serum, 1 mM sodium pyruvate solution, 2 mM 
MEM non-essential amino acid solution, 0.1 mM l-glutamine, 
100 U/mL penicillin, and 100 μg/mL streptomycin for 1 h at 37°C 
in a humidified atmosphere with 5% CO2, to allow monocytes to 
adhere to the plastic plate. Non-adherent cells were eliminated 
by washing, and adherent cells, enriched for monocytes (≥95% 
purity, as determined by flow cytometry by use of CD14 as a 
marker of the monocytic population), were cultured for 6 days 
for differentiation into macrophages, in RPMI-1640 medium 
supplemented with 10% (v/v) heat-inactivated FBS, 1  mM 
sodium pyruvate solution, 2 mM MEM non-essential amino acid 
solution, 0.1 mM l-glutamine, 100 U/mL penicillin, 100 μg/mL 
streptomycin, and recombinant human (rh) M-CSF at 5 ng/mL, 
at 37°C in a humidified atmosphere with 5% CO2. The resulting 
hMDMs were polarized by incubation with rhIFN-γ (30  ng/
mL), or rhIL-4 (50 ng/mL), or rhIL-10 (20 ng/mL) for 48 h. The 
concentration of the cytokines was established in dose–response 
experiments. For experiments, polarized or non-polarized mac-
rophages were harvested by gentle pipetting. Less than 1% cell 
death was observed in all conditions. Macrophages from each 
different donor were polarized in independent experiments. 
Non-polarized macrophages are referred to as M0 macrophages, 
and hMDMs polarized with IFN-γ, IL-4, or IL-10 are referred to 
as Mϕ-IFN-γ, Mϕ-IL-4, or Mϕ-IL-10, respectively.
expression of surface Molecules  
by Flow cytometry
Expression of surface markers on hMDMs was analyzed by flow 
cytometry (Attune Acoustic Focusing Flow Cytometer, Applied 
Biosystem, Foster City, CA, USA). Fluorochrome-labeled 
monoclonal antibodies specific for CD14, CD11b, CD11c, CD80, 
CD86, CD206, CD209, CD163, CD64, CD32, CD16, and CD13 
were used. Equivalent concentrations of matched isotype con-
trols were included. Before staining, Fc receptors were blocked 
with 10% autologous human serum. Cells were fixed in 1% 
paraformaldehyde and analyzed by flow cytometry. The surface 
expression levels of each marker were measured on polarized 
and non-polarized macrophages of each individual donor. The 
panel of surface molecules was selected based on the reports of 
human cells (22–31), as well as potential involvement of specific 
molecules in macrophage activation. Data were analyzed with 
Attune® Cytometric Software version 1.2.5, compatible with both 
Blue/Violet and Blue/Red configurations. Values are expressed as 
the mean fluorescence intensity (MFI) of the marker of interest 
and as the ratio of the MFI of the marker over the MFI of the same 
marker on non-polarized cells from the same donor.
rna isolation, Dnase Treatment,  
and cDna synthesis
Polarized or non-polarized macrophages (3 × 106) were harvested 
and lysed in TRIZOL (Invitrogen). Total RNA was extracted 
according to the manufacturer’s protocol. The precipitated RNA 
was dissolved in RNase-free water. The quality of the RNA was 
assessed by measuring the ratio of absorbance at 260 and 280 nm 
and by visualization of the integrity of the 28S and 18S bands in 
agarose gels. RNA samples were treated with DNase to remove 
contaminating DNA. Briefly, 10 μg total RNA was treated with 
TURBO DNase for 30  min at 37°C. Digestion was stopped by 
addition of DNase inactivation reagent, for 5 min at room tem-
perature. The samples were centrifuged, and the supernatant con-
taining RNA was recovered. For first-strand synthesis of cDNA 
from RNA molecules, 1 μg RNA was incubated with oligo-dT 
12–18 primer for 5 min at 70°C, and dNTPs and M-MLV-RT were 
added. The mixture was incubated for 60  min at 37°C and for 
15 min at 75°C.
gene expression analysis by  
Quantitative real-time Pcr
Quantitative real-time PCR was performed using gene-specific 
primers designed using Primer Express (Applied Biosystems). The 
primers are shown in Table 1. Quantitative RT-PCR (qRT-PCR) 
analyses were set up using 1.0 μL cDNA, 5 μL of SYBR®Green 
PCR Master Mix (Life Technologies), 0.25 μL of each forward and 
reverse primer (250 nM), 0.2 μL of uracil-N-glycosylase (Applied 
Biosystems), and 3.5 μL of injectable water, totalizing a final vol-
ume of 10 μL. Reactions were run in a 7500 Fast Real-Time PCR 
Table 1 | Primers pairs used for determination of gene expression by 
qrT-Pcr.
gene specific primers pair bp exon
HPRT Forward: TTATGGACAGGACTGAACGTCTTG 24 2–3
Reverse: CCAGCAGGTCAGCAAAGAATT 21
Product: 
114 bp
FCGR1 Forward: GGGCAAGTGGACACCACAA 19 1–2
Reverse: TGCAAGGTTACGGTTTCCTCTT 22
Product: 
83 bp
FCGR2A Forward: GGCTTCTGCAGACAGTCAAGC 21 2–3
Reverse: CCTGGAGCACGTTGATCCAC 20
Product: 
80–77 bp
FCGR2B Forward: GCAGTTCCAAAAGAGAAGGTTTCT 24 8
Reverse: TCGGTTATTTGGGACCATATTGT 23
Product: 
97 bp
FCGR3A Forward: GGTGCAGCTAGAAGTCCATATCG 23 4–5
Reverse: GAATAGGGTCTTCCTCCTTGAACA 24
Product: 
77 bp
4
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system (Applied Biosystems) under the following conditions: 
50°C for 2 min, 95°C for 10 min, 40 cycles of 95°C for 15 s, and 
60°C for 1 min. Melting curve analysis was carried out at the end 
of each PCR to confirm the specificity of PCR products.
Results were analyzed using the 7500 software (7500/7500 
Fast Real-time PCR System) and were normalized using the 
endogenous gene HPTR-1 and the ΔΔcycle threshold method. 
Data are expressed in terms of relative mRNA levels in polarized 
macrophages to mRNA levels in non-polarized cells (M0). Ten rep-
licates per experimental condition were performed, and differences 
were assessed with one-way ANOVA test with Tukey post hoc test.
cytokine secretion
To analyze the cytokine secretion profile of non-stimulated 
polarized macrophages, hMDMs were treated or not treated with 
rhIFN-γ, rhIL-4, or rhIL-10 for 48 h. The cells were collected and 
washed three times with PBS, pH 7.4; fresh media was added, and 
the cells were incubated for additional 24 h. The cell-free culture 
supernatants were collected and used to quantitatively measure 
IL-8, IL-1β, IL-6, IL-10, TNF-α, and IL-12p70 protein levels 
using the Cytometric Bead Array (CBA) Human Inflammatory 
Cytokines Kit. To determine the cytokine secretion by stimula-
tion, polarized macrophages were stimulated for 24 h with LPS, 
a ligand for cell surface TLR4. The cell-free culture supernatants 
were used to quantitatively measure IL-8, IL-1β, IL-6, IL-10, 
TNF-α, and IL-12p70 protein levels by CBA. The assays were 
performed according to the manufacturer’s instructions and ana-
lyzed using flow cytometry. The amount of each cytokine in the 
supernatant was extrapolated using a standard curve based of the 
known amounts of the recombinant cytokine. The concentrations 
of the standards ranged from 20 to 5,000 pg/mL.
Phagocytosis through Fcγri, Fcγrii, or 
cD13 (selective Phagocytosis)
Sheep red blood cells (SRBCs) were maintained in Alsever’s 
solution until used. Modified SRBCs were prepared as described 
previously (14). In brief, erythrocytes (at 1.2 × 109/mL in PBS-
BSA 0.1%) were stained with 10 mM CFSE. The stained SRBCs 
were incubated with 250 μg/mL Sulfo-NHS-biotin for 20 min at 
4°C. After washing, they were coated with 35 μg/mL streptavidin 
for 20 min at 4°C. The biotin-streptavidin-coated erythrocytes 
were washed and incubated with biotinylated F(ab′)2 frag-
ments of goat anti-mouse IgG for 30 min. SRBCs labeled with 
CFSE and coated with biotin, streptavidin, and fragments of 
biotinylated anti-IgG antibodies are henceforth designated EBS-
Fab. For phagocytosis assays, 1 ×  106 hMDMs were incubated 
with 2 μg of Fab fragments of mAb452 (anti-human CD13), or 
4 μg Fab fragments of mAb32.2 (anti-human FcγRI), or 4 μg 
Fab fragments of mAbIV.3 (anti-human FcγRII), or 4 μg IgG1 
(isotype-matched control), or without treatment (control) for 
30 min at 4°C, washed, and incubated with EBS-Fab at a ratio of 
1 monocytic cell:20 EBS-Fab, at 37°C for 30 min. Equivalent sam-
ples were incubated at 4°C as negative controls of phagocytosis. 
Non-internalized erythrocytes were lysed by hypotonic shock. 
Phagocytosis was quantified by flow cytometry (Attune acoustic 
focusing flow cytometer; Applied Biosystems, Foster City, CA, 
USA), with addition of Trypan blue 0.02% in PBS 1× (pH 4.5), 
to quench extracellular fluorescence from attached but not 
internalized erythrocytes. Data are expressed as the percentage 
of CFSE-positive cells (i.e., cells that have ingested at least one 
erythrocyte) and as phagocytic index (PI), calculated using the 
following formula: PI = (% CFSE-positive cells) × (MFI of cells 
containing erythrocytes). Results were analyzed using Attune® 
Cytometric Software version 1.2.5, compatible with both Blue/
Violet and Blue/Red configurations.
Phagocytosis of Escherichia coli and 
Zymosan Particles
Human monocyte-derived macrophages were treated or not 
treated with rhIFN-γ, rhIL-4, or rhIL-10 for 48 h. The hMDM 
suspension (1 × 106 polarized or non-polarized cells) was incu-
bated with 20 μL of fluorescein-conjugated heat-killed E. coli 
suspension or with 40 μg/mL of fluorescein-conjugated zymosan 
particles for 30 min at 37°C. Negative controls were prepared 
in identical conditions but incubated at 4°C. Phagocytosis was 
stopped by washing the suspension of hMDM and bacteria or 
zymosan particles with ice-cold PBS. Each sample was ana-
lyzed immediately after addition of Trypan Blue 0.02% in PBS 
1× (pH 4.5), to quench extracellular fluorescence from attached 
but not internalized bacteria or particle. Data are expressed as 
the percentage of FITC-positive cells. Results were analyzed 
using Attune® Cytometric Software version 1.2.5, compatible 
with both Blue/Violet and Blue/Red configurations.
Quantification of rOs Production
Human monocyte-derived macrophages, non-polarized or 
treated with rhIFN-γ, rhIL-4, or rhIL-10, were collected and 
washed with HBSS. Cell suspensions (1  ×  106 hMDM) were 
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incubated for 30 min at 4°C in HBSS with 2 μg of Fab fragments 
of mAb452 (anti-CD13), or 4  μg Fab fragments of mAb32.2 
(anti-human FcγRI), or 4 μg Fab fragments of mAbIV.3 (anti-
human FcγRII), or 4 μg murine IgG1 (isotype-matched control), 
or in HBSS alone (control No Fab). After a brief centrifugation, 
the supernatant was discarded, and the cells were loaded with a 
cell-permeable ROS-sensitive fluorescent dye, by incubating with 
20 mM carboxy-H2DFFDA, for 30 min at 37°C in HBSS. After 
washing, the receptors FcγRI, FcγRII, and CD13 were crosslinked 
for 30 min at 37°C by incubation with EBS-Fab at a ratio of 1 
cell:20 EBS-Fab. To maximize contact, the cells mixed with the 
EBS-Fab were pelleted by a brief centrifugation. The cells were 
resuspended and transferred to wells of black 96-well Immuno 
Plates (Thermo Scientific, Waltham, MA, USA). Fluorescence 
from oxidized carboxy-H2DFFDA was determined immediately 
(initial reading) and every 15  min thereafter, in a Cytation 
3 Cell Imaging Multi-Mode Reader (BioTek, Winooski, VT, 
USA) for 60 min. For quantification of ROS production in M2 
macrophages, cells were preincubated on ice with two different 
Fab fragments [anti-FcγRI (32.2) +  anti-FcγRII (IV.3), or anti-
FcγRI (32.2) +  anti-CD13 (452)], or with three Fab fragments 
(32.2 + IV.3 + 452), or no treatment (No Fab). Subsequently, cells 
were washed and loaded with carboxy-H2DFFDA. Cells were 
mounted in Black 96-well plates and read immediately and every 
30 min thereafter, for 150 min.
statistical analysis
Statistical analysis was performed using GraphPad-Prism soft-
ware (GraphPad, La Jolla, CA, USA). Data are expressed as the 
mean ± SD. One-way ANOVA was used to compare among M0, 
Mϕ-IFN-γ, Mϕ-IL-4, and Mϕ-IL-10, followed by Tukey’s post hoc 
test for comparisons between groups. Statistical significance was 
considered with p < 0.05. For analysis of the expression of surface 
markers using normalization of data (Figures 1D–F; Figure 2B, 
lower plots), ANOVA was used to compare among Mϕ-IFN-γ, 
Mϕ-IL-4, and Mϕ-IL-10, followed by Tukey’s post hoc test for 
comparisons between treatment groups.
resUlTs
Distinct cell surface Markers expression 
by Polarized Macrophages
To characterize phenotypically the macrophage populations 
polarized in vitro, we determined the expression of a panel of 
surface molecules by flow cytometry after 2  days of in  vitro 
polarization with rhIFN-γ, rhIL-4, or rhIL-10, using non-
polarized cells (M0) as a control. The cell surface molecules 
analyzed were CD163, CD209, CD206, CD14, CD11b, CD11c, 
CD80, and CD86; these markers were selected based on litera-
ture reports, and the involvement of these molecules in mac-
rophage activation (22–33). Figures  1A–C show the MFIs for 
each marker observed in cells from 30 different donors, whereas 
Figures 1D–F show the same data expressed as the ratio of the 
MFI of the marker of interest on cytokine-polarized cells over 
the MFI of the same marker on non-polarized cells from the 
same donor, to show more clearly the effect of each treatment 
on membrane expression of the markers. Macrophages treated 
with IL-10 (Mϕ-IL-10) showed a specific upregulation of the 
expression of the scavenger receptor CD163 (mean 5.2-fold 
increase) (p < 0.001), as compared to non-polarized and IL-4 
or IFN-γ polarized macrophages (Figures  1A,D; Figure S1 
in Supplementary Material). IL-4 induced the expression of 
CD209 [dendritic cell-specific ICAM-3-grabbing non-integrin 
(DC-SIGN)], a C-type lectin (mean 4.9-fold increase) (p < 0.001) 
and an increase in the expression of CD206 (mannose recep-
tor C-type 1) (mean 3.9-fold increase) (p <  0.001). CD209 is 
expressed neither in M0 macrophages nor in Mϕ-IFN-γ or 
Mϕ-IL-10 and therefore is a useful marker for Mϕ-IL-4 (34). 
Also, expression of CD11b is increased (mean 2.3-fold increase) 
(p < 0.001), and expression of CD14 is significantly decreased 
(to an average of half the value of M0 cells) (p < 0.001) in Mϕ-IL-
4, compared with M0, Mϕ-IFN-γ, or Mϕ-IL-10 (Figures 1B,E; 
Figure S1 in Supplementary Material). Finally, Mϕ-IFN-γ dis-
played a robust and specific upregulation of the costimulatory 
molecules CD80 (mean 4.9-fold) (p < 0.001) and CD86 (mean 
3.6-fold) (p < 0.001) compared to M0, Mϕ-IL-4, and Mϕ-IL-10 
(Figures 1C,F; Figure S1 in Supplementary Material). We did 
not find significant differences in CD11c expression among 
the different subpopulations of macrophages (Figure S1 in 
Supplementary Material). In summary, human Mϕ-IL-10 are 
characterized by high expression of CD163; Mϕ-IL-4 specifi-
cally upregulates CD209, CD206, and CD11b and downregulate 
CD14; and Mϕ-IFN-γ specifically upregulates the expression of 
the costimulatory molecules CD80 and CD86.
Once validated the surface markers for Mϕ-IL-10, Mϕ-IL-
4, and Mϕ-IFN-γ polarized in  vitro, we investigated the effect 
of polarization on membrane expression of FcγRs and CD13. 
Figure  2A shows representative histograms, and Figure  2B 
shows plots of the MFI values, both as MFI and as relative 
expression normalized to the expression on non-polarized cells 
from the same donor. Mϕ-IL-10 showed a specific upregula-
tion of FcγRIII (CD16) (mean 2.4-fold increase) compared to 
all other macrophage populations (p <  0.001). Mϕ-IL-10 also 
showed an increased expression of the high-affinity FcγRI 
(CD64) compared to M0 or Mϕ-IL-4 (mean 2.5-fold increase) 
(p  <  0.001) (Figures  2A,B). CD64 was also significantly 
increased in Mϕ-IFN-γ (CD64high) compared to all other mac-
rophages populations (mean 4.5-fold increase with respect to 
M0) (Figures 2A,B). Although both IL-10 and IFN-γ induced an 
increased expression of CD64 in comparison to non-polarized 
macrophages (p < 0.001), the expression induced by IFN-γ is sig-
nificantly higher than the expression induced by IL-10 (p < 0.05) 
(Figures 2A,B). We did not find significant differences in FcγRII 
(CD32) or CD13 expression among different populations of 
macrophages (Figure 2A). These results suggest that the expres-
sion levels of FcγRs (but not of CD13) are differently modulated 
by the macrophage activation phenotype.
The effects of the polarizing cytokines on the levels of mRNA 
coding for FcγRs were evaluated by quantitative RT-PCR. 
Compared to the non-polarized macrophages (M0), Mϕ-IFN-γ 
have significantly higher FcγRI (CD64) mRNA levels (FcγRI, 
mean 72.5-fold increase, p < 0.001) (Figure 2C). In Mϕ-IL-10, 
mRNA levels of FcγRI and FcγRIII (CD16) were significantly 
FigUre 1 | continued
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increased (FcγRI, mean 27.1-fold increase, p <  0.01; FcγRIII, 
mean 39.7-fold increase, p <  0.001). The elevated mRNA level 
of FcγRI observed in macrophages treated with IFN-γ correlates 
with the increased membrane expression (Figure 2B). Likewise, 
the increased mRNA levels of FcγRI and FcγRIII in Mϕ-IL-10 
(Figure 2C) agree with the increases in membrane expression of 
these receptors (Figure 2B). Thus, IFN-γ and IL-10 modulate the 
expression of FcγRs at the mRNA level.
FigUre 1 | continued 
cell surface markers expressed on in vitro polarized macrophages. Monocytes from peripheral blood of healthy donors were cultured for 6 days in medium 
containing macrophage colony-stimulating factor to differentiate into M0. The resulting human monocyte-derived macrophages were polarized by incubation with 
IFN-γ (30 ng/mL), IL-4 (50 ng/mL), or IL-10 (20 ng/mL) for 48 h and subsequently analyzed by flow cytometry for the expression of surface markers. (a–c) Mean 
fluorescence intensity (MFI) of each marker in non-polarized and polarized cells from 30 individual donors. (D–F) Fold increase in MFI relative to control (non-
polarized macrophages) of cells from 30 individual donors polarized with IFN-γ, IL-4, or IL-10. Plots are grouped in lines to show (a,D) markers upregulated in 
Mϕ-IL-10 (upper plot), (b,e) markers upregulated or downregulated in Mϕ-IL-4 (middle-line plots), and (c,F) markers upregulated in Mϕ-IFN-γ (lower line plots). 
(a–c) One-way ANOVA was used to compare among M0, Mϕ-IFN-γ, Mϕ-IL-4, and Mϕ-IL-10 followed by Tukey’s post hoc test for comparisons between treatment 
groups. For analysis of the expression of surface markers using normalization of data (D–F), ANOVA was used to compare among Mϕ-IFN-γ, Mϕ-IL-4, and 
Mϕ-IL-10, followed by Tukey’s post hoc test for comparisons between treatment groups (**p < 0.01 and ***p < 0.001).
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All populations of macrophages express substantial levels of 
FcγRII on their membrane (Figure 2A). Although the histograms 
show no difference among the different populations, the RT-PCR 
analysis indicates differences in the ratio of FcγRIIa/FcγRIIb 
among the polarized macrophages (Figure  2C). This ratio is 
higher in Mϕ-IL-10 and lower in Mϕ-IL-4 and Mϕ-IFN-γ. 
Because the FcγRIIa isoform contains in its intracellular portion 
an activatory ITAM, while FcγRIIb contains an inhibitory ITIM, 
these differences are likely to be important in the triggering of 
effector functions through stimulus that engage FcγRII.
cytokine secretion by Polarized 
Macrophages
To analyze the cytokine secretion profile of the different popula-
tions of polarized macrophages, the polarizing cytokines were 
completely removed by washing after 48  h. Fresh media with 
or without LPS was added, and the cells were incubated for 
additional 24  h. Cell-free culture supernatants were used for 
determination of the production of IL-8, IL-6, IL-1β, IL-10, 
TNF-α, and IL-12p70. Unstimulated Mϕ-IL-10 secreted a low, 
yet significant amount of IL-10 (p < 0.05), whereas unstimulated 
Mϕ-IFN-γ produced significant levels of TNF-α compared to the 
other macrophage populations analyzed (p <  0.05) (Figure 3). 
In the absence of stimulation, Mϕ-IL-4 macrophages did not 
produce significant levels of any cytokine examined (Figure 3).
After stimulation with LPS for 24  h, macrophage subsets 
showed distinct profiles of cytokine production. In Mϕ-IFN-γ, 
LPS stimulation induced significant secretion of IL-8, IL-6, 
TNF-α, IL-1β, and IL-12p70 compared to non-polarized 
macrophages and macrophages treated with IL-4 or IL-10 (all 
p < 0.001) (Figure 3). In contrast, upon LPS stimulation, Mϕ-
IL-10 and Mϕ-IL-4 secreted significantly higher amounts of 
IL-10 (p <  0.001 and p <  0.01, respectively) compared to M0 
macrophages. Mϕ-IFN-γ macrophages also produced significant 
levels of IL-10 upon stimulation with LPS (p <  0.05) although 
to a lesser degree than Mϕ-IL-10 and Mϕ-IL-4 macrophages 
(Figure 3). Thus, macrophages activated to different phenotypes 
exhibited a specific cytokine profile in both resting state and 
response to LPS stimulation.
M0 and Mϕ-il-10 Macrophages show 
higher Fcγr-Mediated Phagocytosis
To determine whether differences in the expression of FcγRs 
observed among the different subpopulations of in vitro polarized 
macrophages (Figure 2) are reflected at the functional level, we 
examined phagocytosis mediated by FcγRs in non-polarized and 
polarized macrophages.
We used an experimental system to direct sheep erythrocytes 
(as the phagocytic prey) to individual receptors on the cell, as 
reported previously (14). Erythrocytes loaded with CFSE and 
labeled with biotin and streptavidin were coated with biotin-
F(ab′)2 fragments of goat anti-mouse IgG (EBS-Fab). These EBS-
Fabs specifically interact with the molecules on the cell surface 
tagged with bound Fab fragments of specific murine mAb. As the 
specificity of the system is based on antibodies and macrophages 
express FcγRs, we used Fab fragments to exclude any possible con-
tribution of Fc fragments binding to FcγRs to the phagocytosis. 
Cells were preincubated on ice with Fab fragments of anti-FcγRI 
mAb32.2 (Fab32.2) or Fab fragments of anti-FcγRII mAb IV.3 
(Fab IV.3) or no treatment (basal phagocytosis, designated as No 
Fab). Cells were washed, mixed with EBS-Fab, and incubated at 
37 or 4°C for 30 min. After incubation, non-internalized erythro-
cytes were lysed by hypotonic shock. The percentage of cells with 
internalized erythrocytes (CFSE-positive cells) and the MFI of 
the CFSE-positive cells was determined by flow cytometry after 
quenching extracellular fluorescence with Trypan blue.
Binding of EBS-Fab to the cells through FcγRI induced its effi-
cient internalization by Mϕ-IL-10 (mean 39.5%) (p < 0.001) and 
by non-polarized macrophages (M0) (mean 35.8%) (p < 0.001) 
compared with EBS-Fab internalization by cells not treated with 
Fabs (basal phagocytosis) (mean 8.26%; Figures 4A,B). Mϕ-IL-4 
exhibited a poor internalization of EBS-Fab through FcγRI (mean 
14.5%), which was not significantly different from basal phago-
cytosis. Mϕ-IFN-γ showed the lowest uptake of EBS-Fab (mean 
7.2%), which was similar to phagocytosis of EBS-Fab by M0 cells 
with no Fab (basal phagocytosis) (Figure 4B). As expected, no 
significant internalization was observed when identical samples 
were kept at 4°C (Figure 4A, lower dot plots). To compare the 
PIs (PI = % CFSE-positive cells multiplied by mean fluorescence 
intensity), we first normalized the PI values of each sample to the 
basal phagocytosis of EBS-Fabs (cells not treated with Fabs) of 
cells from the same donor (which was given a value of 1). This was 
done to correct from differences in CFSE labeling of erythrocytes 
and in basal phagocytosis by cells from each different donor. 
Comparison of PI of phagocytosis mediated by FcγRI showed 
similar results to those obtained from comparing the percentage 
of CFSE-positive cells (Figure 4C). However, unlike the results 
of percentages, the mean PI of internalization through FcγRI 
by Mϕ-IL-10 (19.2-fold increase) (p <  0.001) was significantly 
higher than the mean PI of M0 (non-polarized) macrophages 
(13.8-fold increase) (Figure  5C). Thus, Mϕ-IL10 showed the 
FigUre 2 | effect of polarization on membrane expression of Fcγrs and cD13. Monocytes from healthy donors were cultured for 6 days in a medium 
supplemented with macrophage colony-stimulating factor (M-CSF) to differentiate into M0. The resulting human monocyte-derived macrophages were polarized by 
incubation with IFN-γ (30 ng/mL), IL-4 (50 ng/mL), or IL-10 (20 ng/mL) for 48 h and subsequently analyzed by flow cytometry for the expression of FcγRI, FcγRII, 
FcγRIII, and CD13. (a) Representative histograms of cells from a single donor. The arrows indicate significant changes in receptor expression induced by 
polarization. Colored histograms are from cytokine-treated cells. (b) Upper plots show the mean fluorescence intensity (MFI) of FcγRI and FcγRIII in non-polarized 
and polarized cells from 30 individual donors, and lower plots show the same data plotted as average fold increase in MFI relative to control (non-polarized 
macrophages or M0). (c) After polarization, cells were lysed, and RNA was isolated for quantification of mRNA for FcγRI, FcγRIIa, FcγRIIb, and FcγRIII by real-time 
PCR. Average fold increase of mRNA relative to non-polarized macrophages in cells from 10 different donors analyzed in triplicate. Results are expressed as 
mean + SD of independent experiments. Statistical significance was calculated using one-way ANOVA with Tukey post hoc test. For analysis of the expression of 
FcγRs using normalization of data [(b), lower plots] ANOVA was used to compare Mϕ-IFN-γ, Mϕ-IL-4, and Mϕ-IL-10, followed by Tukey’s post hoc test for 
comparisons between treatment groups (*p < 0.05 and ***p < 0.001).
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highest phagocytosis mediated through FcγRI compared to all 
other macrophage populations, followed by non-polarized mac-
rophages that were significantly more phagocytic than Mϕ-IL-4 
and Mϕ-IFN-γ.
The binding of EBS-Fab to the cells through FcγRII induced 
its efficient internalization by non-polarized macrophages (M0) 
(mean 49.4%) (p < 0.001), Mϕ-IL-10 (mean 48.4%) (p < 0.001), 
and Mϕ-IL-4 (mean 22.8%) (p < 0.01) compared with no treat-
ment (basal phagocytosis) (mean 8.26%; Figures  4D,E). Mϕ-
IFN-γ did not internalize EBS-Fabs through FcγRII (mean 7.2%). 
No significant internalization by polarized or non-polarized 
macrophages was observed when identical samples were kept 
at 4°C (Figure 4D, lower plots). When we compared the PI, we 
observed similar results to those from comparing the percentages 
of CFSE-positive cells (Figure  4F), except that the mean PI of 
internalization through FcγRII by Mϕ-IL-4 (mean 3.47%) was 
not statistically different from basal phagocytosis. Likewise, Mϕ-
IFN-γ (mean 1.6%) exhibited a PI similar to the basal phagocyto-
sis (mean 1.0%) (Figure 4F). There were no significant differences 
in PIs between Mϕ-IL-10 (17.6-fold increase) and non-polarized 
macrophages (16.8-fold increase) for FcγRII-mediated phagocy-
tosis. Thus, similar to the phagocytosis through FcγRI, both M0 
and Mϕ-IL-10 showed significantly higher phagocytosis through 
FcγRII than Mϕ-IL-4 and Mϕ-IFN-γ. The low phagocytosis 
FigUre 3 | cytokine secretion by non-polarized and polarized macrophages. Human monocyte-derived macrophages were polarized by incubation with 
IFN-γ, IL-4, or IL-10 for 48 h. The polarizing stimulus was completely removed by washing, and the cells were incubated for additional 24 h in a fresh medium with 
or without LPS. The cell culture supernatants were recovered, and the concentrations of IL-8, IL-1β, IL-6, IL-10, TNF-α and IL-12p70 were measured by Cytometric 
Bead Array. Results are expressed as mean + SD of independent experiments performed in triplicate with cells from 15 different donors. Statistical significance was 
calculated using one-way ANOVA with Tukey post hoc test (*p < 0.05, **p < 0.01, *** and *§p < 0.001).
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through FcγRII of Mϕ-IL-4 and Mϕ-IFN-γ is consistent with the 
low ratio of FcγRIIa/FcγRIIb in this population (Figure 2C).
We also evaluated phagocytosis of IgG-opsonized SRBC 
(involving the participation of all FcγRs expressed by the cell) 
by M0, Mϕ-IFN-γ, Mϕ-IL-4, and Mϕ-IL-10. All populations 
of macrophages internalized both non-opsonized and IgG-
opsonized SRBC, but to different extents. M0 macrophages 
showed percentages of phagocytosis of non-opsonized SRBCs of 
12.1% and of 52.9% for phagocytosis of IgG-opsonized SRBCs 
(Figure S2 in Supplementary Material). As reported previously 
(35), treatment of hMDM with IFN-γ resulted in a significantly 
reduced FcγRs-mediated phagocytosis (mean 14.8%) (p < 0.001) 
compared with M0 macrophages and also a lower phagocytosis of 
non-opsonized SRBC (mean 8.1%) (Figure S2 in Supplementary 
Material). In contrast, Mϕ-IL-10 showed a significantly higher 
phagocytosis of IgG–SRBC (mean 74.6%) (p <  0.001) and of 
non-opsonized SRBC (mean 15.4%). Mϕ-IL-4 showed an inter-
mediate phagocytic capacity between that of Mϕ-IL-10 and that 
of Mϕ-IFN-γ, with percentages of 9.4 and 32.6% for phagocy-
tosis of non-opsonized and IgG-opsonized SRBCs, respectively 
(Figure S2 in Supplementary Material). Similar to the results of 
phagocytosis through FcγRI and through FcγRII, both M0 and 
Mϕ-IL-10 show high phagocytic capacity for IgG-opsonized 
preys, with Mϕ-IL-10 exhibiting the highest phagocytic capacity 
compared to all other populations.
M0 and Mϕ-il-10 Macrophages show 
higher cD13-Mediated Phagocytosis
Even though we did not find differences in CD13 expression 
between different populations of macrophages (Figure 2A), we 
evaluated whether there were differences in CD13-mediated 
phagocytosis of EBS–Fab. The percentages of CFSE-positive cells 
of Mϕ-IL-10 (mean 38.5%) and non-polarized macrophages (M0) 
(mean 25.6%) were statistically significant (p < 0.001) compared 
with basal phagocytosis of EBS-Fab (mean 8.26%) (Figures 5A,B), 
while CD13-mediated phagocytosis by Mϕ-IL-4 (mean 14.3%) or 
Mϕ-IFN-γ (mean 4.3%) was not significantly different from non-
specific phagocytosis of EBS-Fab (Figures 5A,B). No significant 
internalization was observed when identical samples were kept 
at 4°C (Figure  5A, lower dot plots). With respect to the PI of 
specific phagocytosis through CD13, we observed a significant 
increase in PI for Mϕ-IL-10 (12.8-fold increase) (p < 0.001) and 
non-polarized macrophages (11.4-fold increase) (p  <  0.001) 
compared to basal phagocytosis (Figure 5B), while PIs for Mϕ-
IL-4 (mean 1.4%) and Mϕ-IFN-γ (mean 1.4%) (Figure 5B) were 
no different to basal phagocytosis. No significant differences in 
PIs of CD13-mediated phagocytosis were observed between Mϕ-
IL-10 and M0 (non-polarized) macrophages.
Macrophage activation Phenotypes 
Distinctively affect Phagocytosis of 
bacteria and Zymosan Particles
To determine whether the differences found in specific phago-
cytosis through FcγRI, FcγRII, and CD13 are also evident in 
phagocytosis through other receptors, we analyzed the effect of 
polarization on phagocytosis of FITC-labeled E. coli and FITC-
labeled zymosan, using flow cytometry. M0, Mϕ-IL-10, and 
Mϕ-IL-4 efficiently internalized FITC-E. coli; Mϕ-IL-10 showed 
the highest percentage of phagocytosis (mean 93.9%) (p < 0.001) 
FigUre 4 | continued
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FigUre 4 | continued  
Fcγri- and Fcγrii-mediated phagocytosis in non-polarized and polarized human macrophages. Polarized and non-polarized macrophages were 
incubated with 4 μg Fab fragments of mAb32.2 (Fab 32.2; anti-FcγRI) or Fab fragments of mAbIV.3 (Fab IV.3; anti-FcγRII) or without antibody (No Fab) for 30 min at 
4°C. After washing, macrophages were incubated for 30 min at 37 or 4°C with carboxyfluorescein succinimidyl ester (CFSE)-labeled F(ab′)2 goat anti-mouse-
opsonized erythrocytes (EBS-Fab). Non-internalized erythrocytes were lysed, and samples were analyzed by flow cytometry to determine the percentage of 
CFSE-positive cells. (a) Representative dot plots of a single experiment, showing FcγRI-mediated phagocytosis. (b) Average of CFSE-positive cells (M0 and 
polarized macrophages) treated with Fab fragment 32.2 (anti-FcγRI) and incubated with EBS-Fab (n = 15). (c) Phagocytic index (PI) (geometric mean of 
fluorescence intensity multiplied by the percentage of positive cells) of FcγRI-mediated phagocytosis in M0 and polarized macrophages. Data were normalized 
considering the value obtained in the absence of FcγRI crosslinking (No Fab) as 1. (D) Representative dot plot of a single experiment, showing FcγRII-mediated 
phagocytosis. (e) Average of CFSE-positive cells (M0 and polarized macrophages) treated with Fab fragment IV.3 (anti-FcγRII) and incubated with EBS-Fab (n = 15). 
(F) PI of FcγRII-mediated phagocytosis in M0 and polarized macrophages. Data were normalized considering the value obtained in the absence of FcγRII 
crosslinking as 1. Results are expressed as mean + SD of independent experiments. Statistical significance was calculated using one-way ANOVA with Tukey 
post hoc test (***p < 0.001).
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(Figure 6A), while Mϕ-IL-4 (mean 81.3%) showed no significant 
difference with phagocytosis by M0 macrophages (mean 79.1%) 
(Figure 6A). However, the percentage or phagocytic cells in Mϕ-
IFN-γ (mean 20%) (p < 0.001) was significantly lower compared 
to non-polarized macrophages (M0) (mean 79.1%) (Figure 6A). 
No significant internalization was observed when identical 
samples were kept at 4°C (Figure  6A, lower dot plots). The 
reduced phagocytosis shown by Mϕ-IFN-γ cannot be attributed 
to a reduced binding of bacteria, since the binding of bacteria 
to Mϕ-IFN-γ (measured at 4°C) was higher compared with 
non-polarized macrophages and other populations of polarized 
macrophages (data not shown).
With respect to internalization of FITC-labeled zymosan 
particles, Mϕ-IL-4 exhibited the highest level of phagocytic 
cells (mean 69.9%) (p < 0.001) (Figure 6B). Significant phago-
cytic activity of zymosan was observed also for non-polarized 
macrophages (M0) (mean 41.6%) and Mϕ-IL-10 (mean 31.3%) 
(Figure 6B). Mϕ-IFN-γ macrophages showed reduced uptake of 
zymosan particles compared with M0 and Mϕ-IL-4 macrophages 
(Figure  6B) (p  <  0.001). No significant internalization was 
observed when identical samples were kept at 4°C (Figure 6B, 
lower dot plots).
Table  2 summarizes the results of phagocytosis mediated 
by FcγRI, FcγRII, and CD13, as well as phagocytosis of E. coli 
and zymosan, by non-polarized and the three types of polarized 
macrophages.
aggregation of Fcγri, Fcγrii, or cD13 on 
Mϕ-iFn-γ Macrophages induces rOs 
Production
Macrophages are phagocytic cells that produce and release ROS 
in response to phagocytosis or stimulation with various agents. 
ROS generation has been implicated in a variety of physiological 
responses and is a critical component of the antimicrobial reper-
toire of macrophages. Therefore, we investigated whether FcγRI-, 
FcγRII-, or CD13-mediated phagocytosis results in generation of 
ROS in each population of macrophages. Cells were incubated on 
ice with Fab fragments of anti-FcγRI mAb32.2 (Fab 32.2) or Fab 
fragments of anti-FcγRII mAb IV.3 (Fab IV.3) or Fab fragments 
of anti-CD13 (Fab 452) or no treatment (No Fab). After this, 
cells were washed and loaded with carboxy-H2DFFDA (ROS-
sensitive fluorescent dye). Cells were washed, and the receptors 
FcγRI, FcγRII, and CD13 were crosslinked for 30 min at 37°C 
by incubation with EBS-Fab (without CFSE), so as to replicate 
the stimulation leading to phagocytosis. Cells and EBS-Fabs 
were transferred to black 96-well plates, and the fluorescence of 
oxidized carboxy-H2DFFDA was measured at different times. As 
a control, macrophages were also stimulated with heat-killed E. 
coli. In M0 macrophages, phagocytic stimulation through FcγRI, 
FcγRII, and CD13 as well as E. coli, induced a slow ROS response 
that after 150 min became significantly higher compared to ROS 
production by cells treated only with EBS-Fabs. In contrast, Mϕ-
IFN-γ produced significant amounts of ROS after only 30 min. 
Figure  7 shows ROS production by the different populations 
of polarized macrophages after 60 min of stimulation with dif-
ferent stimuli. To evaluate the effect of the polarization on ROS 
production, the results are shown relative to the ROS produc-
tion induced by each stimulus in M0 cells. Compared to non-
polarized macrophages, crosslinking of FcγRI, FcγRII, or CD13 
induces significantly higher production of ROS in Mϕ-IFN-γ 
when crosslinking was induced by a phagocytable particle (EBS-
Fab) (Figure 7) [Fab 32.2 (α-FcγRI) + EBS-Fabs, mean 16.4-fold 
increase] (p < 0.001); [Fab 452 (α-CD13) + EBS-Fab, mean 11.13-
fold increase] (p < 0.01); (Fab IV.3 [α-FcγRII] + EBS-Fab, mean 
11.9-fold increase) (p < 0.01). The increase in ROS generation by 
phagocytic stimuli through FcγRI, FcγRII, or CD13 was similar 
to the generation of ROS by stimulation with E. coli (positive 
control) (Figure 7) (E. coli, mean 24.4-fold increase) (p < 0.001). 
In contrast, Mϕ-IL-4 and Mϕ-IL-10 showed no difference in ROS 
production compared to M0 cells, after 60 min of stimulation by 
FcγRI, FcγRII, or CD13 crosslinking (Figure 7).
Altogether, these results suggest that phagocytosis through 
FcγRI, FcγRII, and CD13 in Mϕ-IFN-γ leads to strong genera-
tion of ROS that could potentially promote the degradation of 
ingested material.
Mϕ-il10 are able to Produce rOs after 
coaggregation of Fcγri, Fcγrii, and cD13
We observed that although Mϕ-IL-10 did not produce significant 
amounts of ROS after crosslinking of FcγRI, FcγRII, or CD13, 
these cells did show a modest but significant ROS production 
after stimulation with E. coli (mean 3.5-fold increase relative to 
M0 macrophages, Figure  7). Although anti-inflammatory M2 
macrophages are usually described as non-ROS-producing cells 
(36), it was recently reported that stimulation with PMA induces 
ROS production by M2 macrophages (37). Thus, we considered 
FigUre 5 | cD13-mediated phagocytosis in non-polarized and polarized macrophages. Non-polarized and polarized macrophages were incubated with 
2 μg Fab fragments of mAb452 (anti-CD13) or without antibody (No Fab) for 30 min at 4°C. After washing, macrophages were incubated for 30 min at 37 or 4°C 
with carboxyfluorescein succinimidyl ester (CFSE)-labeled F(ab′)2 goat anti-mouse-opsonized erythrocytes (EBS-Fab). Non-internalized erythrocytes were lysed, and 
samples were analyzed by flow cytometry to determine the percentage of CFSE-positive cells. (a) Representative dot plots of a single experiment, showing 
CD13-mediated phagocytosis. (b) Average of CFSE-positive cells (M0 and polarized macrophages) treated with Fab of mAb 452 (anti-CD13) and incubated with 
EBS-Fab (n = 15). (c) Phagocytic index (geometric mean of fluorescence intensity multiplied by the percentage of positive cells) of CD13-mediated phagocytosis in 
M0 and polarized macrophages. Data were normalized considering the value obtained in the absence of CD13 crosslinking (No Fab) as 1. Results are expressed as 
mean + SD of independent experiments. Statistical significance was calculated using one-way ANOVA with Tukey post hoc test (***p < 0.001).
Table 2 | summary of major findings in the different activation 
phenotypes.
  MΦ-
M0
MΦ-
iFn-γ
MΦ-
il-4
MΦ-
il-10
Phagocytosis FcγRI mediated ++++ + + +++++
FcγRII mediated ++++ + ++ ++++
CD13 mediated +++ + + ++++
Escherichia coli ++++ + ++++ +++++
Zymosan ++ + ++++ ++
ROS 
production
FcγRI mediated + +++++ 0 +
FcγRII mediated + +++++ 0 +
CD13 mediated + +++++ 0 +
FcγRI-/FcγRII mediated + +++++ 0 +++
FcγRI-/FcγRII-/CD13 
mediated
++ +++++ 0 +++
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the possibility that Mϕ-IL-10 could produce ROS, albeit at levels 
lower than those produced by Mϕ-IFN-γ, and this led us to 
evaluate ROS production at longer times and under stimulation 
by two or more receptors. For this, different subpopulation of 
macrophages were preincubated on ice with Fab fragments of 
anti-FcγRI mAb32.2 (Fab 32.2) alone, or with Fab 32.2 and Fab 
fragments of anti-FcγRII mAb IV.3 (Fab IV.3), or with Fab frag-
ments 32.2 and Fab fragments of anti-CD13 (Fab 452) or with the 
three Fab fragments (32.2, IV.3, and 452), or no treatment (No 
Fab). Subsequently, cells were washed and loaded with carboxy-
H2DFFDA. Cells were washed and incubated for 30 min at 37°C 
with EBS-Fab (without CFSE), so as stimulate phagocytosis. 
Cells and EBS-Fabs were transferred to black 96-well plates, 
and the fluorescence of oxidized carboxy-H2DFFDA was read 
immediately (initial reading) and for 2 h 30 min, with reading 
intervals every 30 min. As a positive control, macrophages were 
also stimulated with heat-killed E. coli. The results are shown in 
Figure 8. Mϕ-IFN-γ generated high levels of ROS after stimula-
tion through FcγRs and CD13 or by E. coli, such that the fluores-
cence signal overflowed the detection limit of the instrument after 
60 min. Mϕ-IL-10, on the other hand, produced ROS at amounts 
that became significant after 90 min of stimulation by E. coli or 
by coaggregation of two (FcγRI and FcγRII or FcγRI and CD13) 
or three (FcγRI + FcγRII + CD13) receptors. ROS production 
by crosslinking of FcγRI alone was significant only after 150 min 
FigUre 6 | Phagocytosis of Escherichia coli and zymosan in non-polarized and polarized macrophages. M0 macrophages were polarized with IFN-γ, 
IL-4, or IL-10 for 48 h. After washing, macrophages were incubated for 30 min at 37 or 4°C with FITC-labeled E. coli or FITC-labeled zymosan particles. Non-
internalized E. coli or zymosan were removed by washing, and samples were analyzed by flow cytometry to determine the percentage of FITC-positive cells in the 
presence of Trypan blue 0.02% in PBS, to quench extracellular fluorescence from attached but not internalized particles. (a) Representative dot plots of a single 
experiment, showing E. coli phagocytosis (left). Bar graph (right) show the average of FITC-E. coli-positive cells (n = 15). (b) Representative dot plot of a single 
experiment, showing phagocytosis of zymosan particles (left). Bar graph show the average of FITC-zymosan positive cells (n = 15) (right). Results are expressed as 
mean ± SD of independent experiments. Statistical significance was calculated using one-way ANOVA with Tukey post hoc test. ns, not significant; ***p < 0.001.
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(Figure  8), while crosslinking FcγRII or CD13 separately did 
not induce significant production of ROS (data not shown). The 
increase in ROS generation by stimulation of Mϕ-IL-10 simulta-
neously through more than one phagocytic receptor was similar 
to the generation of ROS by stimulation with E. coli (Figure 8). 
In contrast, Mϕ-IL-4 did not produce significant levels of ROS 
under any stimulation even after 150 min. These results suggest 
that simultaneous stimulation through Fcγ receptors and CD13 
as well as stimulation with E. coli are strong signals that are able 
to induce ROS production in Mϕ-IL-10 macrophages, although 
this production is significantly lower than ROS generation in 
Mϕ-IFN-γ.
Table 2 summarizes the results of ROS production by non-
polarized and the three types of polarized macrophages after 
stimulation through FcγRI, FcγRII, and CD13 separately and in 
combination.
DiscUssiOn
Macrophages are very plastic cells that can acquire distinct pheno-
types (activation states) under the influence of different cytokine 
microenvironments. Although several authors have shown 
that macrophages treated with different stimuli display altered 
phenotypes or functional capacities, many of these studies are 
limited in that they compare only one particular activation state 
with non-polarized macrophages. To complicate matters more, 
different laboratories have used different activation protocols on 
different human or murine cell populations, making it difficult to 
perform direct comparisons among studies [discussed in Murray 
et al. (4), although centered on the murine system but of equal 
relevance for studies of human cells]. Although macrophage 
activation was initially seen as a dichotomy between classically 
and alternatively activated macrophages, it is now clear that the 
FigUre 7 | aggregation of Fcγri, Fcγrii, or cD13 induces strong reactive oxygen species production in Mϕ-iFn-γ. Non-polarized or polarized 
macrophages were incubated with 4 μg Fab fragments of mAb32.2 (Fab 32.2; anti-FcγRI) or Fab fragments of mAbIV.3 (Fab IV.3; anti-FcγRII) or 2 μg Fab fragments 
of mAb452 (Fab 452; anti-CD13) or without antibody (No Fab) for 30 min at 4°C. The cells were loaded with carboxy-H2DFFDA, for 30 min at 37°C. After washing, 
the receptors FcγRI, FcγRII, and CD13 were crosslinked or not for 30 min at 37°C by incubation with EBS-Fab. The cells were transferred to wells of black 96-well 
Inmuno Plates and the fluorescence from oxidized carboxy-H2DFFDA was determined after incubation for 30 min (total stimulation time: 60 min) as described in 
Section “Materials and Methods.” Data were normalized considering the value obtained for M0 macrophages as 1.0. Stimulation with Escherichia coli was used as a 
positive control. Results are expressed as mean ± SD of independent experiments. Statistical significance was calculated using one-way ANOVA with Tukey 
post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001).
14
Mendoza-Coronel and Ortega Modulation of Phagocytosis in Polarized Macrophages
Frontiers in Immunology | www.frontiersin.org March 2017 | Volume 8 | Article 303
spectrum of macrophage activation states is much more diverse 
(38, 39). Thus, studies aimed at comparing macrophage activa-
tion phenotypes under standardized conditions are necessary 
to create a framework that could serve as a reference for in vivo 
studies of macrophage activation.
In this study, we have compared three populations of acti-
vated (polarized) macrophages, which have been proposed as 
representative of different phenotypes that could be related to 
three important functions of macrophages: inflammation and 
microbial killing, wound repair, and immune regulation (40). 
The different activated populations were induced by the treat-
ment of hMDMs with three archetypical cytokines: IFN-γ, IL-4, 
and IL-10. In much of the macrophage literature, the populations 
resulting from treatment with these cytokines have been referred 
to as M1, M2a, and M2c macrophages, although such designa-
tions have been also used for macrophages polarized under dif-
ferent stimulation protocols. We follow the suggestions of Murray 
et al (4) and refer to these populations as Mϕ-IFN-γ, Mϕ-IL-4, 
and Mϕ-IL-10, as these designations are unambiguous, and refer 
to non-polarized macrophages as M0.
Our first aim was to define specific markers that could be 
used to characterize these distinct polarized macrophage subsets. 
Identification of specific phenotypic markers is important because 
it provides an objective definition of the activation state of the 
cells that we used. Moreover, the activation phenotypes could be 
used as a reference for delineation of the activation phenotype 
of macrophages found in  vivo under different physiological or 
pathological conditions or in  vitro after different activation 
protocols. Also, as more investigators use the same markers to 
characterize and/or define the activation state of the cell popula-
tion studied, this will facilitate unambiguous interpretation of 
results from different groups.
Our results identified CD80, CD86, and CD64high as markers 
for Mϕ-IFN-γ, expression of CD209, upregulation of CD206 and 
CD11b and downregulation of CD14 for Mϕ-IL-4, and expres-
sion of CD163, CD64, and CD16 for Mϕ-IL-10. Ambarus et al. 
(32) previously reported a study to validate specific markers of 
human monocytes cultured with IFN-γ, IL-4, and IL-10. They 
proposed CD80 as the best phenotypic marker for human Mϕ-
IFN-γ, upregulation of CD200R and down regulation of CD14 as 
distinctive of Mϕ-IL-4, and expression of CD163 and CD16 as 
specific markers for Mϕ-IL-10. Some experimental differences 
exist between their study and ours. First, they started cytokine 
treatment on freshly isolated monocytes, while we first incubated 
the isolated monocytes for 6  days with M-CSF (5  ng/mL), to 
perform cytokine treatment on fully differentiated macrophages. 
Although monocyte treatment with M-CSF has been used to 
polarize macrophages to an alternative phenotype (41), the con-
centration we used (5 ng/mL) is at least an order of magnitude 
lower than the ones used in those studies (50–100 ng/mL), and we 
found no significant differences in expression of CD206 between 
cells cultivated with or without M-CSF. We decided to include 
M-CSF during monocyte-to-macrophage differentiation because 
we noticed that M-CSF treatment greatly improved cell viability, 
and the response to cytokines showed less variability among 
cells from different donors. Despite these differences, in general 
FigUre 8 | coaggregation of Fcγri, Fcγrii, and cD13 induces reactive oxygen species production in Mϕ-il-10. Non-polarized or polarized 
macrophages were preincubated on ice with Fab fragments of anti-FcγRI (Fab 32.2) alone, or with Fab 32.2 + Fab fragments of anti-FcγRII (Fab IV.3), or with Fab 
fragments 32.2 + Fab fragments of anti-CD13 (Fab 452) or with three Fab fragments, 32.2 + IV.3 + 452, or no treatment (No Fab). The cells were loaded with 
carboxy-H2DFFDA, for 30 min at 37°C. After washing, the receptors were crosslinked for 30 min at 37°C by incubation with EBS-Fab. The cells were transferred to 
wells of black 96-well Inmuno Plates, and the fluorescence from oxidized carboxy-H2DFFDA was determined immediately and every 30 min as described in Section 
“Materials and Methods.” Results are expressed as mean ± SD of independent experiments (n = 15). Stimulation with Escherichia coli was used as a positive 
control. Statistical significance was calculated using one-way ANOVA with Tukey post hoc test. a = p < 0.01, b = p < 0.001 (***§ = Value overflowed the detection 
limit of the instrument).
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terms, both studies show good agreement, identifying CD80 and 
CD64high as markers of Mϕ-IFN-γ, significant expression of CD206 
and down regulation of CD14 as characteristics of Mϕ-IL-4, and 
expression of CD163 and CD16 as markers for Mϕ-IL-10 [(32) 
Figures 1 and 2]. Both studies observed a significant increase in 
expression of CD86 on Mϕ-IFN-γ, but since this marker has been 
variably found to increase also after IL-4 treatment (32, 42), we 
consider it unsuitable as a specific marker of Mϕ-IFN-γ. With 
respect to Mϕ-IL-4, we found a significant increase in CD209 
(DC-SIGN) and consider it suitable as a characteristic marker 
of this population of polarized macrophages. CD209 has been 
previously reported to be specifically expressed by IL-4 treated 
macrophages (43, 44) and has been proposed as a marker for 
alternatively activated macrophages (45).
Along with the distinctive expression of membrane markers, 
we observed different patterns of cytokine secretion among the 
three different subpopulations of macrophages. Non-polarized 
M0 macrophages did not secret significant amounts of any of the 
cytokines tested, neither without stimulation nor after stimula-
tion with LPS. Basal (unstimulated) cytokine production by 
Mϕ-IFN-γ was characterized by TNF-α, IL-8, and IL-6 secretion 
(Figure 4), although we found statistical difference only for secre-
tion of TNF-α (p < 0.05). Mϕ-IL-10 showed basal expression of 
low levels of IL-10 (p < 0.05) (Figure 3). Upon stimulation with 
LPS, Mϕ-IFN-γ secreted IL-8, IL-6, IL-1β, TNF-α, and IL-12p70, 
with IL-8 being the most abundantly secreted cytokine. Both 
Mϕ-IL-4 and Mϕ-IL-10 stimulated with LPS secreted significant 
levels of IL-10 (p < 0.001). In summary, Mϕ-IFN-γ macrophages, 
which express higher levels of costimulatory molecules, preferen-
tially secrete pro-inflammatory cytokines suggesting that these 
cells are capable of responding efficiently to microbial/endotoxin 
challenges (39), whereas Mϕ-IL-4 and Mϕ-IL-10 macrophages 
produce the anti-inflammatory cytokine IL-10. Although IL-10 
is a hallmark M2 cytokine in the mouse (40), we and others (41) 
have shown that in humans, Mϕ-IFN-γ macrophages stimulated 
with LPS secrete low but significant (compared to non-polarized 
macrophages) levels of IL-10 (p < 0.05) (Figure 4). Thus, based 
on the membrane markers expressed and the cytokines produced, 
it is evident that human Mϕ-IFN-γ have several characteristics of 
what is usually considered as M1 pro-inflammatory macrophages, 
Mϕ-IL-4 have characteristics of M2a (tissue-repairing) mac-
rophages, and Mϕ-IL-10 those of M2c (regulatory) macrophages.
Since we were interested in evaluating FcγR- and CD13-
mediated phagocytosis in the polarized macrophages, we deter-
mined the effect of polarization on the expression of these receptors. 
We observed that CD64 (FcγRI) was significantly upregulated by 
IFN-γ (Figure 2), which agrees with previous reports (31, 32). 
IL-10 also induced an increase in CD64 expression compared to 
the non-polarized and IL-4-treated macrophages, although this 
increase was significantly smaller than the increase induced by 
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IFN-γ (Figure 2). Ambarus and colleagues (32) also observed a 
small increase in CD64 expression in Mϕ-IL10 compared to M0 
and Mϕ-IL-4 cells, although in their experiments, this increase 
was not statistically significant. IL-10 induced also the expres-
sion of FcγRIII (CD16). The membrane expression of CD32 
(FcγRII), as well as the expression of CD13, did not change after 
treatment with any of the polarizing cytokines. Monocytic cells 
can express two CD32 isoforms (FcγRIIa and FcγRIIb). Although 
their extracellular domains are very similar, the receptors have 
opposite functional activities: FcγRIIa is an activating receptor 
that contains an intracellular ITAM, while FcγRIIb isoform is an 
inhibitory receptor that contains an ITIM in its cytoplasmic por-
tion (46). Thus, since changes in the relative expression of the two 
isoforms could affect functions mediated by FcγRII, we analyzed 
by qRT-PCR the effect of the different polarizing treatments on 
the expression of mRNA for FcγRI, FcγRIIa, FcγRIIb, FcγRIII, and 
CD13. The results show that although expression of CD32 on the 
membrane was not changed after polarization, the ratios FcγRIIa/
FcγRIIb of activatory/inhibitory isoforms of the receptor were 
distinctly modulated. With respect to the ratio in non-polarized 
cells, the ratio is higher in Mϕ-IL-10 and lower in Mϕ-IL-4 and 
Mϕ-IFN-γ and probably contributes to the higher phagocytosis 
displayed by Mϕ-IL-10, both of IgG-opsonized erythrocytes 
as well as in selective phagocytosis through FcγRII. Significant 
increases in mRNA for FcγRI were observed in Mϕ-IFN-γ and 
Mϕ-IL-10, and in mRNA for FcγRIII in Mϕ-IL-10, which are 
reflected in the membrane expression of these receptors.
By using a phagocytosis assay that allowed us to target labeled 
SRBCs to specific receptors on the cell surface, we were able to 
analyze phagocytosis mediated specifically by FcγRI, FcγRII, 
or CD13. We have recently reported that CD13 is a phagocytic 
receptor in human monocytic cells (14). As shown in Figures 4 
and 5, phagocytosis through each of these receptors follows a 
similar pattern in the different macrophage populations: Mϕ-
IFN-γ showed the lowest phagocytic activity, while Mϕ-IL-10 
were highly phagocytic. M0 cells were also capable of significant 
phagocytosis through the three receptors, only slightly less than 
Mϕ-IL-10. Although IFN-γ induces a significant increase in 
FcγRI expression, phagocytosis through this receptor is signifi-
cantly lower in Mϕ-IFN-γ. In contrast, Mϕ-IL-10, which showed 
a smaller increase in FcγRI expression, showed a significantly 
higher FcγRI-mediated phagocytosis (Figure  4A). Since Mϕ-
IL-10 showed the highest phagocytosis also through FcγRII and 
CD13, which did not show changes in expression, this suggests 
that the phagocytic activity is more dependent on cellular proper-
ties/characteristics other than expression of the corresponding 
receptors on the cell membrane. In line with this suggestion, Mϕ-
IL-4, whose expression of FcγRI, FcγRII, and CD13 on the cell 
membrane was not different from M0 untreated macrophages, 
showed very low levels of phagocytosis through these receptors.
The significantly lower ability of Mϕ-IFN-γ to phagocytose 
through FcγRs and CD13 is also evident in phagocytosis of heat-
killed E. coli and zymosan, which are internalized through dif-
ferent receptors (Figure 6). In contrast, both non-polarized and 
Mϕ-IL-10 internalize both particles very efficiently. However, it 
is not possible to generalize and consider a particular activation 
phenotype as highly or poorly phagocytic, since while Mϕ-IL-4 
are very poorly phagocytic through FcγRs and CD13, these cells 
are as efficient as Mϕ-IL-10 for phagocytosis of E. coli and are the 
population with the highest ability for phagocytosis of zymosan 
particles (Figure 6).
Our results and those of others (19, 47, 48) have shown that 
in human monocytes/macrophages, IL-10 increases phagocytosis 
of E. coli (Figure 6A) and IgG- opsonized particles (Figure S2 in 
Supplementary Material), suggesting that the effects of IL-10 are 
not specific for a particular phagocytic receptor. It is possible that, 
in addition to increasing the expression of phagocytic receptors 
(CD64, CD32, CD16, and scavenger receptor CD163), IL-10 
modulates the expression and/or activation of signaling mol-
ecules involved in phagocytic pathways, resulting in enhanced 
phagocytosis through these receptors, which is one of the features 
of M2c macrophages. IL-10 drives macrophages toward a pheno-
type involved in tissue repair and dampening of inflammation 
(47, 48).
To date, the mechanisms by which IL-10 enhances and IFN-γ 
downregulates phagocytosis are not known. Previous studies 
from our group investigated the effect of IFN-γ and IL-10 on 
phagocytic signaling mediated by FcγRs in monocytic cells (19). 
In that study, it was shown that the inhibition of phagocytosis 
induced by IFN-γ was not accompanied by inhibition of the early 
biochemical events triggered by FcγRs crosslinking. It was found 
that IFN-γ induced a higher basal level of F-actin and activation 
of Rac1, which might be involved in the reduced phagocytic 
capacity of IFN-γ-treated cells. Inhibition of PI3K prevented the 
increase in F-actin induced by IFN-γ. Thus, it was proposed that 
F-actin assembly in response to IFN-γ engages a portion of the 
components necessary for cytoskeleton reorganization, leading 
to impaired responses requiring cytoskeleton rearrangement. 
Previous reports have demonstrated that IFN-γ can diminish 
monocyte responses that depend on cytoskeleton reorganiza-
tion. Thus, monocytes cultured in the presence of IFN-γ showed 
defective internalization of bacteria and SRBC, unopsonized 
or opsonized with C3b/iC3b or IgG (34, 49–51). Here, we also 
found that treatment with IFN-γ inhibits phagocytosis of E. coli 
and IgG-opsonized particles compared with M0, Mϕ-IL-4, and 
Mϕ-IL-10 (Figure 6A).
Phagocytes produce ROS conjunctly with phagocytosis or 
after stimulation with various agents. ROS generation has been 
implicated in a variety of physiological responses and is a critical 
component of the antimicrobial repertoire of phagocytes. Thus, 
we investigated whether FcγRI, FcγRII, and CD13-mediated 
phagocytosis is coupled to ROS production and if this production 
is regulated by the activation phenotype of the cell. Uptake of 
antigens via activating Fcγ receptors (mainly FcγRI and FcγRII) 
has been reported to result in enhanced NADPH oxidase assem-
bly and production of ROS (52). On the other hand, IL-4 induces 
downregulation of the gp91 subunit of the NOX2 complex (53), 
which results in lower production of ROS but increases the reduc-
ing capacity of the phagosome. Our results show a difference in 
ROS production among the different activation phenotypes. 
Mϕ-IFN-γ macrophages have a higher ROS-producing capac-
ity compared to M0, Mϕ-IL-4, and Mϕ-IL-10 macrophages 
(Figure  8). Furthermore, we found that ROS production was 
induced only when the receptors were crosslinked by a phago-
cytable particle, suggesting that ROS production is specifically 
linked to the phagocytic process. As expected, our results indicate 
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that FcγRI, FcγRII, and CD13-mediated phagocytosis induces 
ROS production in Mϕ-IFN-γ macrophages and not in Mϕ-IL-4 
and Mϕ-IL-10 (Figure 8). Traditionally, ROS-producing capac-
ity has been associated with pro-inflammatory macrophages, 
but less with anti-inflammatory macrophages. This is consistent 
with our results. Nevertheless, Kraaij and colleagues (37, 54) 
showed that upon PMA stimulation, M2 subsets have different 
ROS-producing capacity: M2c macrophages have a higher ROS 
production compared to M2a macrophages, which is most 
likely related to a reduced expression of gp91phox by the later. We 
investigated if Mϕ-IL-10 could produce ROS by simultaneous 
stimulation of several phagocytic receptors and found that, while 
in Mϕ-IFN-γ coaggregation of FcγRI/FcγRII/CD13 induces 
a high production of ROS from the first 30 min of stimulation 
(Figure 8), simultaneous stimulation of phagocytic receptors in 
Mϕ-IL-10 does not induce significant production of ROS at the 
same time (30 and 60 min). However, after 90 min of simultane-
ous stimulation through phagocytic receptors or stimulation by E. 
coli, ROS production by Mϕ-IL-10 macrophages is significantly 
higher than in unstimulated cells (Figure  8), and the produc-
tion increases with respect to time. In contrast, simultaneous 
stimulation of several receptors does not induce ROS generation 
by Mϕ-IL-4 macrophages at any time analyzed. In summary, 
Mϕ-IFN-γ and Mϕ-IL-10 macrophages produced significantly 
higher quantities of intracellular ROS compared to M0 and Mϕ-
IL-4 macrophages. The high levels of ROS production by M1 
macrophages has been previously described and is in line with 
their pro-inflammatory role. To our knowledge, ROS production 
associated with phagocytosis in Mϕ-IL-10 macrophages has not 
been reported previously.
The mechanisms and functional relevance of ROS production 
by M2 macrophages has only started to be investigated. Kraaij and 
colleagues (54) compared the expression of two proteins (p47 and 
gp91) of the NOX2 complex in M2a and M2c macrophages. Both 
mRNA and protein expression of p47phox was similar between M2 
subsets, but the mRNA and protein expression of gp91phox were 
lower in M2a compared with M2c macrophages, which correlates 
with the higher production of ROS by M2c macrophages. Although 
ROS production is mainly considered to be pro-inflammatory, 
causing cell and tissue destruction, recent findings have shown 
that ROS is also involved in regulation of immune responses as 
they can have an anti-inflammatory role and prevent autoim-
mune responses (55). In this respect, it is noteworthy that human 
M2 macrophages have been shown to suppress T cell responses 
by induction of T  regulatory cells (Tregs) in a ROS-dependent 
manner (56). Tregs play a critical role in the prevention of 
autoimmunity and resolution of inflammation. Interestingly, the 
immunosuppressive drug dexamethasone was shown to increase 
the ability of M2 macrophages to produce ROS, and injection of 
dexamethasone in rats caused a long-lasting upregulation of ROS 
production by macrophages and induced higher levels of Tregs in 
a ROS-dependent manner (57).
Throughout this study, we compared the phenotype and 
functions of polarized macrophages with those of non-polarized 
macrophages. M0 macrophages could represent a macrophage 
in its “basal” state, probably related to cells resident in tissues in 
homeostasis, in the absence of microbial or cytokine stimulation. 
However, these cells are by no means dormant or quiescent. They 
are actively engaged in maintaining tissue homeostasis and are 
expected to be capable of phagocytosis of apoptotic cells as well 
as bacteria and particulate matter. It is thus no surprising that 
M0 cells showed efficient phagocytosis of all particles tested and 
even a small and late ROS production. In this respect, polarization 
could be considered more an increment or dampening of func-
tions already present in the non-polarized macrophage, rather 
than inducing the appearance of entirely new capacities in the cell.
In conclusion, we have analyzed the expression and the ability 
to mediate effector functions of the phagocytic receptors FcγRs 
and CD13, in three populations of in  vitro polarized human 
macrophages and non-polarized macrophages. We characterized 
these populations in terms of membrane markers and cytokine 
production. We found that the ability to mediate phagocytosis 
and ROS production depend more heavily on the activation state 
of the macrophage than on the expression level of the specific 
receptor. Thus, phenotypic and transcriptomic profiling of dif-
ferently activated cells could serve as a guide for their ability to 
perform specific functions, but it is essential to carry on functional 
experiments. Along these lines, caution should be exerted when 
considering a specific macrophage population with generaliza-
tions such as “highly phagocytic,” as exemplified by Mϕ-IL-4, 
which are highly phagocytic of zymosan particles, but show very 
low FcγR-mediated phagocytosis despite significant expression 
of the later receptors.
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